Population Pharmacokinetics and Exposure–response Relationship of a Muscarinic Receptor Antagonist, Imidafenacin-Reference-Cited by-同舟云学术

Population Pharmacokinetics and Exposure–response Relationship of a Muscarinic Receptor Antagonist, Imidafenacin

Published:2013 Issue:3 Volume:28 Page:203-212
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Hasegawa Chihiro,Ohno Tomoya,Nakade Susumu,Shibakawa Kimio,Miyabe Hiroyuki,Ouchi Takafumi,Ogawa Mikio

Publisher

Japanese Society for the Study of Xenobiotics

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference13 articles.

1. Drugdrug interactions in the metabolism of imidafenacin: Role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes;Kanayama;Xenobiotica,2007

2. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data;Sheiner;J. Pharmacokinet. Biopharm.,1977

3. Population Pharmacokinetic Analysis of a Novel Muscarinic Receptor Antagonist, Imidafenacin, in Healthy Volunteers and Overactive Bladder Patients;Ohno;Drug Metab. Pharmacokinet.,2008

4. Guidance on E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs;International Conference on Harmonisation,2005

5. Development and validation of bioanalytical methods for Imidafenacin (KRP-197/ONO-8025) and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry;Masuda;J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Extended-Release Multiple-Unit System of Imidafenacin Prepared by Fluid-Bed Coating Technique;AAPS PharmSciTech;2018-06-21

2. The role of concentration−effect relationships in the assessment of QTcinterval prolongation;British Journal of Clinical Pharmacology;2014-12-19

3. Imidafenacin for the treatment of overactive bladder;Expert Opinion on Pharmacotherapy;2013-05-06